| Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series T Janowitz, E Gablenz, D Pattinson, TC Wang, J Conigliaro, K Tracey, ... Gut 69 (9), 1592-1597, 2020 | 160 | 2020 |
| Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial CM Brennan, S Nadella, X Zhao, RJ Dima, N Jordan-Martin, ... Gut 71 (5), 879-888, 2022 | 40 | 2022 |
| CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with CancerCamGFR v2 Estimates GFR in Patients … EH Williams, TR Flint, CM Connell, D Giglio, H Lee, T Ha, E Gablenz, ... Clinical Cancer Research 27 (5), 1381-1390, 2021 | 12 | 2021 |
| Neurotensin neurons in the extended amygdala control dietary choice and energy homeostasis A Furlan, A Corona, S Boyle, R Sharma, R Rubino, J Habel, EC Gablenz, ... Nature Neuroscience, 1-11, 2022 | 7 | 2022 |
| Multicenter prospective cohort study of the patient-reported outcome measures PRO-CTCAE and CAT EORTC QLQ-C30 in major abdominal cancer surgery (PATRONUS): A student-initiated … AL Mihaljevic Annals of Surgical Oncology 28, 3075-3089, 2021 | 7 | 2021 |
| Neurotensin neurons in the central extended amygdala control energy balance A Furlan, A Corona, S Boyle, R Sharma, R Rubino, J Habel, EC Gablenz, ... BioRxiv, 2021.08. 03.454970, 2021 | 1 | 2021 |
| Abstract S04-01: Famotidine use and quantitative symptom tracking for COVID-19 in nonhospitalized patients: A case series T Janowitz, EC Gablenz, DJ Pattinson, TC Wang, J Conigliaro, KJ Tracey, ... Clinical Cancer Research 26 (18_Supplement), S04-01-S04-01, 2020 | 1 | 2020 |
